» Articles » PMID: 7676619

Attenuated Mutants of Venezuelan Equine Encephalitis Virus Containing Lethal Mutations in the PE2 Cleavage Signal Combined with a Second-site Suppressor Mutation in E1

Overview
Journal Virology
Specialty Microbiology
Date 1995 Sep 10
PMID 7676619
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The PE2 cleavage signal in a full-length cDNA clone of the alphavirus Venezuelan equine encephalitis virus (VEE) was ablated by site-directed mutagenesis. RNA transcripts derived from the resulting plasmids programmed the production of nonviable particles upon transfection of baby hamster kidney (BHK) cells. However, the mutant RNAs also gave rise to a small proportion of viable revertants. Analysis of these biological revertants and their molecularly cloned homologs demonstrated that second-site suppressor mutations at either E2 position 243 or E1 position 253 were able to restore viability to PE2 cleavage signal mutants. The viable revertants incorporated unprocessed PE2 into particles which showed normal infectivity for BHK cells, but reduced ability to grow in C6/36 mosquito cells. A mutant carrying a lethal PE2 cleavage signal mutation in combination with a suppressor at E1 253 was either avirulent or highly attenuated in adult mice when inoculated by the subcutaneous, intracerebral, or intranasal route and conferred complete protection against both intraperitoneal and intranasal challenge with virulent VEE. These results indicate the close functional association of the E2 and E1 proteins in the alphavirus spike. They also have implications for the design of recombinant live virus vaccines for VEE, for other alphaviruses, and for other viruses that use a similar mechanism for glycoprotein maturation.

Citing Articles

Alphavirus-based replicons demonstrate different interactions with host cells and can be optimized to increase protein expression.

Dominguez F, Palchevska O, Frolova E, Frolov I J Virol. 2023; 97(11):e0122523.

PMID: 37877718 PMC: 10688356. DOI: 10.1128/jvi.01225-23.


Venezuelan Equine Encephalitis Virus V3526 Vaccine RNA-Dependent RNA Polymerase Mutants Increase Vaccine Safety Through Restricted Tissue Tropism in a Murine Model.

Haines C, Campos R, Azar S, Warmbrod K, Kautz T, Forrester N Zoonoses (Burlingt). 2022; 2.

PMID: 35262074 PMC: 8900488. DOI: 10.15212/zoonoses-2021-0016.


Engineering a fidelity-variant live-attenuated vaccine for chikungunya virus.

Weiss C, Liu H, Riemersma K, Ball E, Coffey L NPJ Vaccines. 2020; 5:97.

PMID: 33083032 PMC: 7560698. DOI: 10.1038/s41541-020-00241-z.


Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose.

Rossi S, Russell-Lodrigue K, Plante K, Bergren N, Gorchakov R, Roy C Vaccines (Basel). 2020; 8(3).

PMID: 32887313 PMC: 7563393. DOI: 10.3390/vaccines8030497.


Measuring Alphavirus Fidelity Using Non-Infectious Virus Particles.

Patterson E, Khanipov K, Swetnam D, Walsdorf S, Kautz T, Thangamani S Viruses. 2020; 12(5).

PMID: 32429270 PMC: 7291308. DOI: 10.3390/v12050546.